Plus Therapeutics Inc
F:XMPA
Plus Therapeutics Inc
F:XMPA
Price:
0.2
EUR
-11.11%
Market Cap:
€1.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Plus Therapeutics Inc
F:XMPA
|
US |
|
K
|
KDDI Corp
XMUN:DIP
|
JP |
|
F
|
Fuji Electric Co Ltd
XMUN:FJE
|
JP |
|
T
|
TAG Immobilien AG
F:TEG0
|
DE |
|
H
|
Hasbro Inc
XBER:HAS
|
US |
|
American International Group Inc
F:AINN
|
US |
|
C
|
Commerzbank AG
XMUN:CBK
|
DE |
|
B
|
Banco Santander SA
SWB:BSDK
|
ES |
|
A
|
American International Group Inc
DUS:AINN
|
US |
|
F
|
Faurecia SE
MIL:EO
|
FR |
|
I
|
Impala Platinum Holdings Ltd
XMUN:IPHB
|
ZA |
|
Dar Global PLC
F:L16
|
UK |
|
ASML Holding NV
SIX:ASML
|
NL |
|
Novartis AG
F:NOTA
|
CH |
|
R
|
Republic Services Inc
SWB:RPU
|
US |
|
L
|
Laboratory Corporation of America Holdings
DUS:LAB
|
US |
|
A
|
Avis Budget Group Inc
XMUN:CUCA
|
US |
|
G
|
General Dynamics Corp
F:GDX
|
US |
|
A
|
Applied Materials Inc
XHAM:AP2
|
US |
|
M
|
Marriott International Inc
SWB:MAQ
|
US |
|
B
|
Bureau Veritas SA
XMUN:4BV
|
FR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XMPA's stock price target?
Not Available
XMPA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Plus Therapeutics Inc?
Projected CAGR
101%
101%
Over the last 13 years, the compound annual growth rate for Revenue has been -8%. The projected CAGR for the next 6 years is 101%.
